Filing Details

Accession Number:
0001567619-21-013660
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-19 19:03:09
Reporting Period:
2021-07-15
Accepted Time:
2021-07-19 19:03:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623715 Imago Biosciences Inc. IMGO Pharmaceutical Preparations (2834) 454915810
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757917 Omega Fund Vi, L.p. 888 Boylston St., Suite 1111
Boston MA 02199
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-15 250,000 $16.00 250,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported securities are beneficially owned by Omega Fund VI, L.P. ("Omega VI"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. ("Omega VI GP"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. ("Omega VI GP Manager"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI.